Tag: Vaccine Production

3P Biopharmaceuticals signed a contract manufacturing agreement with Intervacc

3P Biopharmaceuticals, a Spanish biotechnology company, and the Swedish company Intervacc completed negotiations and signed the agreement for contract manufacturing of Strangvac®.

In 2017 Nanolek demonstrates the first results of its active market development

In 2017, the revenue of Nanolek LLC reached 2.6 billion rubles, which is a 3-fold increase compared to 2016. The output of medicinal products at the Nanolek plant in the Kirov region amounted to 8.1 million packages.

Vnesheconombank restructures the debt of Ryazan-based FORT

Vnesheconombank allowed FORT, a pharmaceutical manufacturer based in Ryazan, to continue using its credit facility on the terms favorable for the company

Anton Katlinsky says that Russia cannot wait in a queue to get the vaccines

Anton Katlinsky, the Advisor to the CEO of Nacimbio and the President of FORT, a biopharmaceutical company, discussed with other experts the scenarios for provision of vaccines to the Russian market

Panacea Biotech signs an important deal with Serum Institute of India

Panacea Biotech Ltd., India's leading biopharmaceutical company and the largest manufacturer of vaccines, has signed two long-term collaboration agreements with Serum Institute of India

MSD considers the possibility of localizing the vaccines manufacturing in Russia

According to Marwan Akar, MSD Director General in Russia, Kazakhstan and Belarus, the company is exploring the possibility of localizing in Russia the manufacturing of vaccines

St. Petersburg Institute of Vaccines and Serums joins DCVMN

In November 2017, St. Petersburg Institute of Vaccines and Serums joined the Developing Countries Vaccine Manufacturers Network

Nacimbio will invest 2.2 billion rubles in vaccine manufacturing

The Governor of the Ryazan region and the President of FORT LLC have signed an agreement to extend the provision of state support

NANOLEK will cover the needs for inactivated polio vaccine in Russia

Polymilex, an inactivated polio vaccine, is the first IPV fully manufactured in Russia

Vaccination will become a driver of economic growth in the 21st century

Nikolai Briko, Doctor of Medical Sciences and Member of the Scientific and Technical Council of Nacimbio, said that this century is the age of vaccines

Sanofi funds new vaccine manufacturing facility in France

Sanofi is investing €170 million to expand a vaccine manufacturing site in Val de Reuil, France

Bavarian Nordic achieved contract for vaccines supply for U.S. Government

Bavarian Nordic, a Danish biotech, announced the award of a sole source contract from the Biomedical Advanced Research and Development Authority

Nacimbio presents its new products at the international conference

Nacimbio presented to the scientific community the results of the study of epidemiological efficacy of the flu vaccines manufactured by the enterprises of the holding company.

Petrovax presented the results of clinical trials for quadrivalent vaccine

NPO Petrovax Pharm presented the results of clinical trials for the first Russian-made quadrivalent vaccine

NANOLEK becomes the first Russian partner of SK Chemicals from Korea

NANOLEK announced its cooperation in the area of joint research, development, and manufacturing of vaccines with SK Chemicals

Rostec will start to produce five new vaccines in the next five years

Oleg Yevtushenko, the Executive Director of Rostec Corporation, announced the plans to expand the national calendar of vaccinations by using new vaccines. Their manufacturing will be set up at the fac...